Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Aug 30.

Published in final edited form as: Microvasc Res. 2012 Nov 6;85:112–117. doi: 10.1016/j.mvr.2012.10.010

Table 1.

Subject Characteristics (n=53; 26 men, 27 women).

	Mean±SD	Range	R²
Age (years)	52±8	40–70	0.011
Total Cholesterol (mg/dL)	207±47	138–320	0.275^*
HDL (mg/dL)	54±15	31–99	0.003
Total Cholesterol/HDL	4.1±1.4	2.3–8.1	0.19^*
LDL (mg/dL)	131±40	72–233	0.303^*
Oxidized LDL (U/L)	64±23	21–131	0.214^*
Soluble LOX-1 receptors (pg/mL)	44±16	14–76	0.259^*
Triglycerides (mg/dL)	111±56	41–310	0.102^*
Fasting glucose (mg/dL)	93±8	78–114	0.007
ADMA (μmol/L)	0.45±0.14	0.21–0.76	0.031
Framingham risk	6.8±4.9	1.1–22.4	0.032

^*

p<0.05 for the relation to functional cutaneous NO-dependent vasodilation.